Cancer Center Director - 50% Effort George J. Weiner, M.D. As HCCC Director, Dr. Weiner, provides overall authority for the Holden Comprehensive Cancer Center's research and administrative activities for the Center. This includes the Core resources, grants aligned with the Center, institutional and private funds. Please see """"""""Essential Characteristics"""""""" for his background and qualifications. He is responsible for the direction for strategic planning activities of the Center, both short-term and long-term, and setting the direction for the goals for cancer research activities at the University of Iowa. Dr. Weiner designates and ensures the effective and efficient leadership of the HCCC as they relate to the overall goals and mission of the Center. He works with Senior Leadership and Program Leaders in the review and development of new Cancer Center programs, cores and research directions based on the strategic planning activities. He promotes communication and collaboration among cancer investigators and collaborations with other institutions. He reports scientific and budgetary progress to the University, the federal government and other funding agencies. Dr. Weiner serves on the Hospital Advisory Committee, the governing body of the Ul Hospitals and Clinics. The HCCC Director is also a member of the Strategic Planning Subcommittee for the Hospital. He is a member of the College of Medicine / College of Public Health Research Advisory Council (currently serving as elected chair), the Medical Council, which is the governing body of the College of Medicine, the Ul HealthCare Senior Executive Leadership Council that sets the agenda for the Ul Medical Center including how the Ul Hospitals and Clinics and the College of Medicine interact with outside agencies and groups and the Institutional Review Board Executive Committee. This committee provides oversight to the IRB, and deals with the more difficult and controversial issues that are brought to the committee. Dr. Weiner chairs the HCCC's Associate Director's Meetings and the Executive Committee Meetings. His role in consultation with the Membership Committee reviews and determines the membership of the HCCC. Working in consult with the Space Committee, he assigns laboratory and clinical research space in the Center based on their recommendations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-10
Application #
7900747
Study Section
Subcommittee G - Education (NCI)
Project Start
2009-07-01
Project End
2010-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
10
Fiscal Year
2009
Total Cost
$241,355
Indirect Cost
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Vijapura, Charmi; Yang, Limin; Xiong, Jinhu et al. (2018) Imaging Features of Nonmalignant and Malignant Architectural Distortion Detected by Tomosynthesis. AJR Am J Roentgenol 211:1397-1404
Brooks, Nathan A; Boland, Riley S; Strigenz, Michael E et al. (2018) Nongenitourinary complications associated with robot-assisted laparoscopic and radical retropubic prostatectomy: A single institution assessment of 1,100 patients over 11 years. Urol Oncol 36:501.e9-501.e13
Sandgren, Jeremy A; Deng, Guorui; Linggonegoro, Danny W et al. (2018) Arginine vasopressin infusion is sufficient to model clinical features of preeclampsia in mice. JCI Insight 3:
Jiang, Cheng-Fei; Shi, Zhu-Mei; Li, Dong-Mei et al. (2018) Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer. Mol Cancer 17:83
Moss, Jennifer L; Xiao, Qian; Matthews, Charles E (2018) Patterns of cancer-related health behaviors among middle-aged and older adults: Individual- and area-level socioeconomic disparities. Prev Med 115:31-38
Monga, Varun; Maliske, Seth M; Kaleem, Hassan et al. (2018) Discrepancy between treatment goals documentation by oncologists and their understanding among cancer patients under active treatment with chemotherapy. Eur J Cancer Care (Engl) :e12973
Swami, Umang; Lenert, Petar; Furqan, Muhammad et al. (2018) Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti-PD-L1 Immunotherapy Be Administered after Anti-PD-1-Related Immune Toxicities? J Thorac Oncol 13:e102-e103
Seaman, Aaron T; Dukes, Kimberly; Hoffman, Richard M et al. (2018) The complicated 'Yes': Decision-making processes and receptivity to lung cancer screening among head and neck cancer survivors. Patient Educ Couns 101:1741-1747
Shields, Anthony F; Jacobs, Paula M; Sznol, Mario et al. (2018) Immune Modulation Therapy and Imaging: Workshop Report. J Nucl Med 59:410-417
Alexander, Matthew S; Wilkes, Justin G; Schroeder, Samuel R et al. (2018) Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer. Cancer Res 78:6838-6851

Showing the most recent 10 out of 1080 publications